GCP
YARW

GSA Capital Partners’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

GSA Capital Partners’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,079
Closed -$31K – 2203
2025
Q4 		$31K Buy
1,079
+361
+50% +$7.25K ﹤0.01% 1592
2025
Q3 		$12K Buy
718
+449
+167% +$14.7K ﹤0.01% 1594
2025
Q2 		$22K Buy
+269
New +$17.5K ﹤0.01% 1689
2022
Q2 		– Sell
-263
Closed -$154K – 1835
2022
Q1 		$154K Buy
263
+21
+9% +$12.5K 0.02% 1227
2021
Q4 		$222K Buy
242
+139
+135% +$149K 0.03% 1144
2021
Q3 		$128K Buy
+103
New +$200K 0.01% 1302

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GSA Capital Partners's YARW Position: Q1 2026 in Review

GSA Capital Partners sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026, closing a stake of 1,079 shares — an estimated $31K sold.

GSA Capital Partners first reported a position in YARW in Q3 2021 and held it in 6 quarters. The position peaked at $222K in Q4 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • GSA Capital Partners reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 1,079 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $31K.
  • GSA Capital Partners first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • GSA Capital Partners's Yarrow Bioscience, Inc. Common Stock position peaked at $222K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.